Recent broker research reports which have the highest upside or maximum gain potential. Both buy and sell
reports with maximum gain with respect to their targets are available.
Broker Research reports: Maximum gain potential
for all stocks
Despite the release of the all-time blockbuster, Pushpa 2, PVRINOX (PVR)’s footfall remained stable QoQ at 25.7%, due to weaker performance from the Hindi language movies.
Balrampur Chini Mills’ (BCML’s) Q2FY2025 numbers were affected by government restrictions in distillery operations and lower crushing volumes. Revenues fell by 16% y-o-y and EBIDTA fell by 70% y-o-y (EBIDTA margins decreased to 3.8%).
Krsnaa Diagnostics Limited’s (KDL’s) revenue decreased due to seasonal factors and temporary operational issues. The Mumbai BMC project ended earlier than expected, and the Maharashtra city and Madhya Pradesh MRI installations experienced delays due to site handover issues which led to a temporary dip in revenues.
Polycab India’s (POLYCAB) 3QFY25 revenue grew ~20% YoY to INR52.3b (in line), as lower-than-estimated revenue in the C&W segment was offset by higher-than-estimated revenue in the FMEG and EPC segments.
KEI Industries (KEII)’s 3QFY25 revenue grew 20% YoY (in line, as strong revenue growth in the C&W/SSW segment offset lower-than-estimated EPC revenue). Its EBITDA grew ~12% YoY to INR2.4b (3% miss). OPM contracted 70bp YoY to 9.8% (-70bp vs. our estimate) due to a lower margin in the C&W segment.